Korea FilingsFull brief — $39

SAMSUNG PHARMACEUTICAL.CO.,Ltd.

삼성제약(주) · KOSPI: 001360 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
삼성제약(주)
Market / ticker
KOSPI · 001360
Industry
Pharmaceuticals and medicinal chemicals
Established
1929-08-15
Fiscal year ends
December
Website
www.sspharm.co.kr
DART corp code
00126414
Latest revenue
₩46.1B (FY2025)

Items worth checking

medium
Operating loss in both FY2024 and FY2025.
medium
Decision to issue convertible / warrant / exchangeable bonds — the filing states whether new or treasury shares back it — filed 2026-09-02.
medium
Litigation filed or ruled — filed 2026-05-08.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩52.0B₩44.3B₩46.1B
Operating income−₩18.0B−₩14.8B−₩18.1B
Net income−₩24.8B−₩14.1B₩11.5B
Total assets₩93.5B₩128.5B₩167.4B
Total liabilities₩15.9B₩22.6B₩46.4B
Total equity₩77.6B₩105.9B₩121.0B
Share capital₩33.6B₩47.1B₩47.1B

Separate statements · FY2025 operating margin -39.2% · liabilities to equity 38% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 72 (current)삼덕회계법인Unqualified
Term 71 (prior)삼덕회계법인Unqualified
Term 70 (two years prior)삼일회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-11Results of share or equity-linked bond issuance (voluntary)DART
2026-09-02Material event report — Convertible bond issuance decisionDART
2026-08-25Large shareholding (5%+) reportDART
2026-08-14Half-year report (2026.06)DART
2026-08-12Material event reportDART
2026-07-01Amended: Material management matterDART
2026-06-30Material management matterDART
2026-06-01Corporate governance reportDART
2026-05-15Quarterly report (2026.03)DART
2026-05-08Litigation rulingDART
2026-03-26Independent director appointment / dismissal / resignationDART
2026-03-26Annual general meeting resultsDART
2026-03-18Annual report (2025.12)DART
2026-03-18Audit report submittedDART
2026-03-11Proxy solicitation reference documentDART
2026-03-11Notice of shareholders meetingDART
2026-03-11Resolution to convene shareholders meetingDART
2026-02-09Revenue or profit structure changed materiallyDART
2026-01-20Material management matterDART
2026-01-16Material event reportDART

Showing the 20 most recent of 27 filings. The full brief lists all of them.

Full brief on SAMSUNG PHARMACEUTICAL.CO.,Ltd. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.